Main Menu

News & Insights

Using predictive analytics to bolster medication adherence

New Hampshire Board of Medicine Recognizes Venebio Opioid Advisor™ as Approved Prescription Opioid Risk Assessment Tool

How Many Scientists Does It Take to Name a Company?

Study Revealing Highest Risk Profiles for Prescription Opioid Overdose to be Published in Next Issue of Pain Medicine

Pain Medicine to Publish Study Validating Venebio Opioid Advisor’s Ability to Identify Patients at Risk of Prescription Opioid Overdose

GAO Report: CMS Needs to Broaden Opioid Efforts to Identify and Address Those at Risk for Serious Harm